Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LenisUSA appears to have been a U.S. commercial brand and distribution venture for the LENIS needle-free injection system rather than a drug-development biotech company. Public materials indicate it operated as Premier Distributing, a division or DBA of Premier Media Services Inc. in Arizona, and held exclusive U.S. distribution rights for the LENIS Needle-Free Injection System beginning in 2018. The product was positioned for administration of a range of injectable medications and supplements through a spring-powered needle-free delivery device for subcutaneous and intramuscular use. In 2019, LenisUSA announced that the system had received a Vizient Innovative Technology contract designation. Current evidence for an active standalone operating company is limited, and the entity appears to have been a private commercial/distribution business rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LenisUSA.